X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,881,160 | -36.8% | 2,642,915 | +12.5% | 0.00% | -100.0% |
Q2 2023 | $4,559,407 | +372.7% | 2,350,210 | +112.0% | 0.00% | – |
Q1 2023 | $964,555 | +165346.8% | 1,108,684 | +88.7% | 0.00% | – |
Q4 2022 | $583 | -99.9% | 587,516 | +19.0% | 0.00% | – |
Q3 2022 | $844,000 | +363.7% | 493,657 | +160.4% | 0.00% | – |
Q2 2022 | $182,000 | -43.1% | 189,548 | +3.4% | 0.00% | – |
Q1 2022 | $320,000 | -21.4% | 183,277 | +2.9% | 0.00% | – |
Q4 2021 | $407,000 | -56.7% | 178,060 | 0.0% | 0.00% | – |
Q3 2021 | $941,000 | -10.6% | 178,060 | +10.0% | 0.00% | – |
Q2 2021 | $1,052,000 | -52.7% | 161,917 | -37.3% | 0.00% | – |
Q1 2021 | $2,222,000 | +34.8% | 258,165 | +0.7% | 0.00% | – |
Q4 2020 | $1,648,000 | +0.2% | 256,454 | +5.5% | 0.00% | – |
Q3 2020 | $1,645,000 | -22.6% | 242,988 | +6.6% | 0.00% | – |
Q2 2020 | $2,124,000 | +1.4% | 227,972 | +8.9% | 0.00% | -100.0% |
Q1 2020 | $2,094,000 | -45.9% | 209,419 | -42.1% | 0.00% | – |
Q4 2019 | $3,870,000 | +166.0% | 361,842 | +215.9% | 0.00% | – |
Q3 2019 | $1,455,000 | -15.0% | 114,532 | +0.4% | 0.00% | – |
Q2 2019 | $1,711,000 | +663.8% | 114,081 | +784.2% | 0.00% | – |
Q1 2019 | $224,000 | – | 12,902 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |